Nobel Prime Medicare Services And Research Profile
Key Indicators
- Authorised Capital ₹ 1.01 Cr
as on 31-12-2024
- Paid Up Capital ₹ 0.13 M
as on 31-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 20.15 Cr
as on 31-12-2024
- Satisfied Charges ₹ 20.75 Cr
as on 31-12-2024
- Revenue 10.12%
(FY 2022)
- Profit -4.97%
(FY 2022)
- Ebitda -40.95%
(FY 2022)
- Net Worth 25.23%
(FY 2022)
- Total Assets 7.96%
(FY 2022)
About Nobel Prime Medicare Services And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 0.13 M.
The company currently has active open charges totaling ₹20.15 Cr. The company has closed loans amounting to ₹20.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Alka Sethi and Prabhakar Sethi serve as directors at the Company.
- CIN/LLPIN
U85110RJ2007PTC024326
- Company No.
024326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2007
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nobel Prime Medicare Services And Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alka Sethi  | Director | 30-Apr-2007 | Current |
| Prabhakar Sethi | Director | 07-Feb-2020 | Current |
Financial Performance of Nobel Prime Medicare Services And Research.
Nobel Prime Medicare Services And Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.12% increase. The company also saw a slight decrease in profitability, with a 4.97% decrease in profit. The company's net worth Soared by an impressive increase of 25.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nobel Prime Medicare Services And Research?
In 2022, Nobel Prime Medicare Services And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jan 2024 | ₹11.50 Cr | Open |
Axis Bank Limited Creation Date: 17 Aug 2020 | ₹1.00 Cr | Open |
Others Creation Date: 19 Sep 2017 | ₹2.70 Cr | Open |
How Many Employees Work at Nobel Prime Medicare Services And Research?
Nobel Prime Medicare Services And Research has a workforce of 17 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nobel Prime Medicare Services And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nobel Prime Medicare Services And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
